Investigation and class action lawsuits against Cynosure and Sanofi-Aventis alleging that these companies sent out millions of facsimiles in violation of a federal statute that prohibits mass faxing to persons who have not consented to receive such faxes.
Name (Stock Symbol)
Cynosure, Inc. (CYNO)
Cynosure, Inc. develops and markets aesthetic treatment systems to the dermatology, plastic surgery, and general medical markets.
Aventis Pharmaceuticals (SNY)
Aventis Pharmaceuticals merged and became part of Sanofi-Aventis. It is a large pharmaceutical company.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.